None listed
Conditions
Brief summary
This study is designed to assess if ibuprofen changes the metabolic profile of paracetamol when given as a fixed dose combination.
Interventions
Intervention: Maxigesic as a single oral dose of two tablets (total dose paracetamol 1000mg and ibuprofen 300mg). Cross-over study with a 7 day washout period between doses. Participants will be fasted for at least 10 hours overnight before the administration of the study drug. Standardised meals will be provided from 4 hours after study drug administration. Drinking water will be restricted for 1 hour before and after drug administration (not including the standardised 240mL of water given with the study drug.
Sponsors
Study design
Eligibility
Inclusion criteria
1) Provide written informed consent 2) Have Body Mass Index between 18.5 and 30.0 kg/m2 3) Healthy volunteers as determined by medical history, physical examination, ECG, vital signs and laboratory tests
Exclusion criteria
1) Women who are pregnant or nursing 2) Women who are unwilling to take adequate contraceptive precaustions or who are unwilling to undergo urine pregnancy testing 3) History of alcohol or drug abuse or dependency 4) Have a history of allergy or hypersensitivity to ibuprofen, aspirin, any other NSAID or paracetamol 5) Have haemopoetic, renal or hepatic disease, immunosupression. Have a history of gastric ulceration, indigestion, stomach pain, GI bleeding or bleeding disorders. Are currently suffering from dehydration from diarrhoea and/or vomiting. Have a history of severe asthma. Have a history of severe hypertension, ventricular tachycardia or other cardiac disease. Have insulin dependent diabetes mellitus.